Tokyo, Nov. 6 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059654) titled 'Hemostatic Single 8 Gy radiotherapy for Tumor bleeding Palliation' on Nov. 6.
Study Type:
Observational
Primary Sponsor:
Institute - National Cancer Center
Condition:
Condition - All cancers with tumor-related bleeding
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - To evaluate hemostatic efficacy following a single 8 Gy palliative radiotherapy
Basic objectives2 - Efficacy
Eligibility:
Age-lower limit - 20
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - 1) Patients scheduled to receive radiotherapy with a single ...